'en:blca-4'
(id=8226471 ; fe=en:blca-4 ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=315 creation date=2017-07-23 touchdate=2025-12-20 11:34:45.000) ≈ 9 relations sortantes
- en:blca-4 --
r_associated #0: 31 / 1 ->
en:matrin-3
n1=en:blca-4 | n2=en:matrin-3 | rel=r_associated | relid=0 | w=31
- en:blca-4 --
r_associated #0: 31 / 1 ->
en:nuclear protein
n1=en:blca-4 | n2=en:nuclear protein | rel=r_associated | relid=0 | w=31
- en:blca-4 --
r_associated #0: 28 / 0.903 ->
en:nuclear matrix
n1=en:blca-4 | n2=en:nuclear matrix | rel=r_associated | relid=0 | w=28
- en:blca-4 --
r_associated #0: 27 / 0.871 ->
en:lamin
n1=en:blca-4 | n2=en:lamin | rel=r_associated | relid=0 | w=27
- en:blca-4 --
r_associated #0: 27 / 0.871 ->
en:protein hira
n1=en:blca-4 | n2=en:protein hira | rel=r_associated | relid=0 | w=27
- en:blca-4 --
r_associated #0: 20 / 0.645 ->
en:glioma-associated antigen
n1=en:blca-4 | n2=en:glioma-associated antigen | rel=r_associated | relid=0 | w=20
- en:blca-4 --
r_associated #0: 20 / 0.645 ->
en:tumor marker
n1=en:blca-4 | n2=en:tumor marker | rel=r_associated | relid=0 | w=20
- en:blca-4 --
r_associated #0: 20 / 0.645 ->
en:urinary bladder tumor antigen
n1=en:blca-4 | n2=en:urinary bladder tumor antigen | rel=r_associated | relid=0 | w=20
- en:blca-4 --
r_associated #0: 20 / 0.645 ->
marqueur tumoral
n1=en:blca-4 | n2=marqueur tumoral | rel=r_associated | relid=0 | w=20
| ≈ 13 relations entrantes
- en:glioma-associated antigen ---
r_associated #0: 34 -->
en:blca-4
n1=en:glioma-associated antigen | n2=en:blca-4 | rel=r_associated | relid=0 | w=34
- en:matrin-3 ---
r_associated #0: 34 -->
en:blca-4
n1=en:matrin-3 | n2=en:blca-4 | rel=r_associated | relid=0 | w=34
- en:tumor marker ---
r_associated #0: 32 -->
en:blca-4
n1=en:tumor marker | n2=en:blca-4 | rel=r_associated | relid=0 | w=32
- marqueur tumoral ---
r_associated #0: 32 -->
en:blca-4
n1=marqueur tumoral | n2=en:blca-4 | rel=r_associated | relid=0 | w=32
- en:lamin ---
r_associated #0: 30 -->
en:blca-4
n1=en:lamin | n2=en:blca-4 | rel=r_associated | relid=0 | w=30
- en:nuclear matrix ---
r_associated #0: 28 -->
en:blca-4
n1=en:nuclear matrix | n2=en:blca-4 | rel=r_associated | relid=0 | w=28
- en:protein hira ---
r_associated #0: 27 -->
en:blca-4
n1=en:protein hira | n2=en:blca-4 | rel=r_associated | relid=0 | w=27
- en:urinary bladder tumor antigen ---
r_associated #0: 26 -->
en:blca-4
n1=en:urinary bladder tumor antigen | n2=en:blca-4 | rel=r_associated | relid=0 | w=26
- en:nuclear protein ---
r_associated #0: 21 -->
en:blca-4
n1=en:nuclear protein | n2=en:blca-4 | rel=r_associated | relid=0 | w=21
- en:tumoral marker ---
r_associated #0: 21 -->
en:blca-4
n1=en:tumoral marker | n2=en:blca-4 | rel=r_associated | relid=0 | w=21
- Marqueur tumoral ---
r_associated #0: 20 -->
en:blca-4
n1=Marqueur tumoral | n2=en:blca-4 | rel=r_associated | relid=0 | w=20
- antigène tumoral de la vessie ---
r_associated #0: 5 -->
en:blca-4
n1=antigène tumoral de la vessie | n2=en:blca-4 | rel=r_associated | relid=0 | w=5
- marques bitemporales de forceps (syndrome des) ---
r_associated #0: 5 -->
en:blca-4
n1=marques bitemporales de forceps (syndrome des) | n2=en:blca-4 | rel=r_associated | relid=0 | w=5
|